Results
21,218 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 |  August PflugerRSelf |  WBDWarner Bros. Discovery, Inc. - Series A Common StockSale | SELL | $1,001 – $15K | Mar 19, 2026 traded Feb 10, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 | August PflugerRSelf | WBDWarner Bros. Discovery, Inc. - Series A Common Stock Sale | SELL | $1,001 – $15K | Mar 19, 2026 traded Feb 10, 2026 | |
Wills Phillip R. IIIDirector |
 FVCBFVCBankcorp, Inc.Open-market sale |
| SELL |
| $170K 11.5K sh |
| Mar 19, 2026 traded Mar 17, 2026 |
| 28 | Liegel Matthew AChief Accounting Officer |  TGTTARGET CORPOpen-market sale | SELL | $241K 2,053 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 28 | Reed Marcy L.Director |  CLHCLEAN HARBORS INCOpen-market sale | SELL | $241K 836 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | von Heynitz HaraldDirector |  FLNCFluence Energy, Inc.Open-market sale | SELL | $165K 10.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Capital V LLC10% Owner |  DSPViant Technology Inc.Open-market sale · 10b5-1 plan | SELL | $180K 15.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $100K 8,760 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 23 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $233K 1,485 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Agrawal NitinChief Financial Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $25K 300 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 22 | Geller AdamChief Product Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $321K 2,094 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 22 | Woolsey Staci MChief Financial Officer |  GVAGRANITE CONSTRUCTION INCOpen-market sale · 10b5-1 plan | SELL | $183K 1,523 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 21 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $563K 16.7K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 21 | Larkin Kyle TDirector, President & CEO | GVAGRANITE CONSTRUCTION INC Open-market sale · 10b5-1 plan | SELL | $877K 7,314 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $117K 3,577 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Beer James ADirector | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 177 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 2,587 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $191K 6,100 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 19 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $177K 15.0K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 18 | Kelly Patrick ArthurCo-President and COO |  CIFRCipher Digital Inc.Open-market sale · 10b5-1 plan | SELL | $533K 35.6K sh | Mar 19, 2026 traded Mar 16, 2026 |
| 16 | Baroni DarioPresident, IDL |  MCDMCDONALDS CORPOpen-market sale · 10b5-1 plan | SELL | $194K 600 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Verjus Nathalie Claude OdileCompany Secretary |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $15K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Peterson JustinChief Technology Officer |  TWTradeweb Markets Inc.Open-market sale · 10b5-1 plan | SELL | $401K 3,212 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 1,461 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,384 103 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $15K 483 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer |  ALABAstera Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $2.44M 18.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $2.98M 22.3K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $5.75M 43.3K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.81M 13.9K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.02M 7,907 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.10M 8,754 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.44M 11.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $3.00M 22.8K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 11 | Wiechmann Andrew C.Chief Financial Officer |  MSCIMSCI Inc.Open-market sale · 10b5-1 plan | SELL | $252K 450 sh | Mar 19, 2026 traded Mar 17, 2026 |